Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02939508 : Should Colon or Non-colon Originated Lesions be Distinguished?
PhasePhase 1/Phase 2
AgesMin: 18 Years Max: 75 Years
Eligibility
Inclusion Criteria:

1. Patients in our ICU aged 18-75 years.

2. Patients with a confirmed diagnosis of ALGID.

Exclusion Criteria:

1. mechanical intestinal obstruction (including tumor, stercoral obstruction etc.)

2. gastrointestinal hemorrhage within 72 hours.

3. history of inflammatory bowel disease (ulcerative colitis or Crohn's disease) or
radiation enteritis.

4. pregnancy.

5. contraindications of neostigmine administration.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02939508      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740